Yao, Chih-Chien <br/><br/>
Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  May 2015 
 - 918-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/jgh.12874  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aging--immunology<br/>Antiviral Agents--therapeutic use<br/>Consolidation Chemotherapy<br/>Female<br/>Follow-Up Studies<br/>Forecasting<br/>Hepatitis B--drug therapy<br/>Hepatitis B e Antigens--blood<br/>Humans<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Nucleotides--immunology<br/>Recurrence<br/>Retrospective Studies<br/>Risk<br/>Seroconversion<br/>Time Factors<br/>Young Adult